New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 4, 2014
08:37 EDTBRLIBio-Reference Labs reports Q1 EPS 11c, consensus 13c
Reports Q1 revenue $181.27M, consensus $171.41M. Marc D. Grodman, MD, CEO, commented, " On our earnings call in December 2013 we provided guidance that our Q1 earnings would be about half those of the prior fiscal year, which was 31c. If it had not been for the weather, that was a solid assessment of where we would be, around 16c when the 5c per share weather factor is taken into consideration."
News For BRLI From The Last 14 Days
Check below for free stories on BRLI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 28, 2014
10:49 EDTBRLIBio-Reference downgraded to Underperform from Buy at BofA/Merrill (pre-open)
Subscribe for More Information
August 27, 2014
08:38 EDTBRLIBio-Reference Labs sees Q4 EPS 62c-64c, consensus 63c
Subscribe for More Information
08:34 EDTBRLIBio-Reference Labs reports Q3 EPS 55c, consensus 53c
Reports Q3 revenue $222.05M, consensus $210.44M. Reports Q3 EPS after taxes 53c. The number of patients served increased 16% to 2,511 in Q3 up from the 3Q13 total of 2,161. Esoteric business for the company was 68% of revenues for Q3 compared to 64% in 3Q13. Days Sales Outstanding, or DSO, was 105 days in Q3 compared to 3Q13 when the DSO was 95 days.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use